Davis AA, Luo J, Zheng T, Dai C, et al. Genomic complexity predicts resistance to endocrine therapy and CDK4/6 inhibition in hormone receptor-positive (HR+)/HER2-negative metastatic breast cancer. Clin Cancer Res 2023 Jan 24:CCR-22-2177. doi: 10.1158/1078-0432.CCR-22-2177.
PMID: 36693175